ro13-9904 and Glioma

ro13-9904 has been researched along with Glioma* in 1 studies

Other Studies

1 other study(ies) available for ro13-9904 and Glioma

ArticleYear
Unusual serological findings associated with ceftriaxone-induced immune hemolytic anemia in a child with disseminated low-grade glioma.
    Pediatric blood & cancer, 2016, Volume: 63, Issue:10

    Ceftriaxone-induced immune hemolytic anemia (CIHA) is the second most common cause of drug-induced hemolytic anemia. Prompt recognition of this drug reaction is essential because brisk hemolysis can be deadly. The extent to which ceftriaxone antibodies persist after CIHA is unknown; rechallenging patients who have experienced CIHA is not recommended. We report a case of CIHA in a neurooncology patient, which is the first to show anticeftriaxone antibodies with Rh specificity and persisted for 8 months after the drug reaction. These findings have implications for understanding the mechanism of CIHA.

    Topics: Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Antibodies; Brain Neoplasms; Ceftriaxone; Child, Preschool; Female; Glioma; Humans

2016